Search

Jehanne Souaya Sitton

Examiner (ID: 9654)

Most Active Art Unit
1634
Art Unit(s)
1655, 1634, 1682
Total Applications
1444
Issued Applications
515
Pending Applications
318
Abandoned Applications
641

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18406152 [patent_doc_number] => 20230167503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES [patent_app_type] => utility [patent_app_number] => 18/160366 [patent_app_country] => US [patent_app_date] => 2023-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10901 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160366 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/160366
METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES Jan 26, 2023 Pending
Array ( [id] => 18552471 [patent_doc_number] => 20230250481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-10 [patent_title] => METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES [patent_app_type] => utility [patent_app_number] => 18/160373 [patent_app_country] => US [patent_app_date] => 2023-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11177 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160373 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/160373
METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES Jan 26, 2023 Pending
Array ( [id] => 18552471 [patent_doc_number] => 20230250481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-10 [patent_title] => METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES [patent_app_type] => utility [patent_app_number] => 18/160373 [patent_app_country] => US [patent_app_date] => 2023-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11177 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160373 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/160373
METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES Jan 26, 2023 Pending
Array ( [id] => 19896817 [patent_doc_number] => 12274711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-15 [patent_title] => Method of determining Acute Myeloid Leukemia response to treatment with farnesyltransferase inhibitors [patent_app_type] => utility [patent_app_number] => 18/147134 [patent_app_country] => US [patent_app_date] => 2022-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14103 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18147134 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/147134
Method of determining Acute Myeloid Leukemia response to treatment with farnesyltransferase inhibitors Dec 27, 2022 Issued
Array ( [id] => 18485355 [patent_doc_number] => 20230212692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => METHOD FOR SORTING COLORECTAL CANCER AND ADVANCED ADENOMA AND USE OF THE SAME [patent_app_type] => utility [patent_app_number] => 18/088405 [patent_app_country] => US [patent_app_date] => 2022-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6756 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18088405 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/088405
METHOD FOR SORTING COLORECTAL CANCER AND ADVANCED ADENOMA AND USE OF THE SAME Dec 22, 2022 Pending
Array ( [id] => 18485355 [patent_doc_number] => 20230212692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => METHOD FOR SORTING COLORECTAL CANCER AND ADVANCED ADENOMA AND USE OF THE SAME [patent_app_type] => utility [patent_app_number] => 18/088405 [patent_app_country] => US [patent_app_date] => 2022-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6756 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18088405 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/088405
METHOD FOR SORTING COLORECTAL CANCER AND ADVANCED ADENOMA AND USE OF THE SAME Dec 22, 2022 Pending
Array ( [id] => 18436520 [patent_doc_number] => 20230183814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => PREDICTIVE BIOMARKERS FOR ONVANSERTIB TREATMENT [patent_app_type] => utility [patent_app_number] => 18/078615 [patent_app_country] => US [patent_app_date] => 2022-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16818 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18078615 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/078615
PREDICTIVE BIOMARKERS FOR ONVANSERTIB TREATMENT Dec 8, 2022 Pending
Array ( [id] => 18436520 [patent_doc_number] => 20230183814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => PREDICTIVE BIOMARKERS FOR ONVANSERTIB TREATMENT [patent_app_type] => utility [patent_app_number] => 18/078615 [patent_app_country] => US [patent_app_date] => 2022-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16818 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18078615 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/078615
PREDICTIVE BIOMARKERS FOR ONVANSERTIB TREATMENT Dec 8, 2022 Pending
Array ( [id] => 18436520 [patent_doc_number] => 20230183814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => PREDICTIVE BIOMARKERS FOR ONVANSERTIB TREATMENT [patent_app_type] => utility [patent_app_number] => 18/078615 [patent_app_country] => US [patent_app_date] => 2022-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16818 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18078615 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/078615
PREDICTIVE BIOMARKERS FOR ONVANSERTIB TREATMENT Dec 8, 2022 Pending
Array ( [id] => 18771214 [patent_doc_number] => 20230366028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-16 [patent_title] => DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE BASED ON GENES [patent_app_type] => utility [patent_app_number] => 18/063931 [patent_app_country] => US [patent_app_date] => 2022-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26911 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063931 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/063931
DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE BASED ON GENES Dec 8, 2022 Pending
Array ( [id] => 18286804 [patent_doc_number] => 20230102276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => APTAMERS FOR THE REVERSIBLE INHIBITION OF DNA POLYMERASES [patent_app_type] => utility [patent_app_number] => 18/057614 [patent_app_country] => US [patent_app_date] => 2022-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6238 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057614 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/057614
APTAMERS FOR THE REVERSIBLE INHIBITION OF DNA POLYMERASES Nov 20, 2022 Pending
Array ( [id] => 18335874 [patent_doc_number] => 20230127823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => Non-Invasive Gene Mutation Detection in Lung Cancer Patients [patent_app_type] => utility [patent_app_number] => 17/931205 [patent_app_country] => US [patent_app_date] => 2022-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13822 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931205 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/931205
Non-Invasive Gene Mutation Detection in Lung Cancer Patients Sep 11, 2022 Pending
Array ( [id] => 18497795 [patent_doc_number] => 20230220485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => CANCER BIOMARKERS AND CLASSIFIERS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/929881 [patent_app_country] => US [patent_app_date] => 2022-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66497 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929881 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/929881
CANCER BIOMARKERS AND CLASSIFIERS AND USES THEREOF Sep 5, 2022 Pending
Array ( [id] => 18497795 [patent_doc_number] => 20230220485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => CANCER BIOMARKERS AND CLASSIFIERS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/929881 [patent_app_country] => US [patent_app_date] => 2022-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66497 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929881 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/929881
CANCER BIOMARKERS AND CLASSIFIERS AND USES THEREOF Sep 5, 2022 Pending
Array ( [id] => 18361657 [patent_doc_number] => 20230143248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => METHOD FOR DIRECT MICROBIAL IDENTIFICATION [patent_app_type] => utility [patent_app_number] => 17/892819 [patent_app_country] => US [patent_app_date] => 2022-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8340 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17892819 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/892819
METHOD FOR DIRECT MICROBIAL IDENTIFICATION Aug 21, 2022 Pending
Array ( [id] => 18242470 [patent_doc_number] => 20230074781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-09 [patent_title] => METHODS AND COMPOSITION FOR THE PREDICTION OF THE ACTIVITY OF ENZASTAURIN [patent_app_type] => utility [patent_app_number] => 17/820772 [patent_app_country] => US [patent_app_date] => 2022-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21956 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820772 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/820772
METHODS AND COMPOSITION FOR THE PREDICTION OF THE ACTIVITY OF ENZASTAURIN Aug 17, 2022 Abandoned
Array ( [id] => 18376021 [patent_doc_number] => 20230151103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => STROMAL GENE SIGNATURES FOR DIAGNOSIS AND USE IN IMMUNOTHERAPY [patent_app_type] => utility [patent_app_number] => 17/886809 [patent_app_country] => US [patent_app_date] => 2022-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44273 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17886809 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/886809
STROMAL GENE SIGNATURES FOR DIAGNOSIS AND USE IN IMMUNOTHERAPY Aug 11, 2022 Abandoned
Array ( [id] => 18164669 [patent_doc_number] => 20230031265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => DEVICES, METHODS AND COMPOSITIONS FOR APTAMER SCREENING [patent_app_type] => utility [patent_app_number] => 17/819051 [patent_app_country] => US [patent_app_date] => 2022-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9022 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819051 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/819051
DEVICES, METHODS AND COMPOSITIONS FOR APTAMER SCREENING Aug 10, 2022 Pending
Array ( [id] => 18164669 [patent_doc_number] => 20230031265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => DEVICES, METHODS AND COMPOSITIONS FOR APTAMER SCREENING [patent_app_type] => utility [patent_app_number] => 17/819051 [patent_app_country] => US [patent_app_date] => 2022-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9022 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819051 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/819051
DEVICES, METHODS AND COMPOSITIONS FOR APTAMER SCREENING Aug 10, 2022 Pending
Array ( [id] => 20116255 [patent_doc_number] => 12365948 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-22 [patent_title] => Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma [patent_app_type] => utility [patent_app_number] => 17/883223 [patent_app_country] => US [patent_app_date] => 2022-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4080 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17883223 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/883223
Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma Aug 7, 2022 Issued
Menu